Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-24
1996-06-25
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546198, A61K 31445, C07D41712
Patent
active
055300111
ABSTRACT:
A compound of formula ##STR1## the racemic mixture, the (S)-form and the acid addition salts thereof, said compound having anti-stroke properties. Pharmaceutical compositions containing this compound as active ingredient and a method of preparing said compound and pharmaceutical compositions.
REFERENCES:
patent: 4861785 (1989-08-01), Stokbroekx et al.
Van Reempts et al. "Structural cell damage and reginal blood flow in the hypoxic brain . . . " Proceedings Inte. Sympsium on Pharm. Cerebral Ischemia, (1986) pp. 385-390.
Grauwels Gilbert A. J.
Stokbroekx Raymond A.
Chang Ceila
Janssen Pharmaceutica N.V.
Metz Charles J.
LandOfFree
4-[(2-benzothiazolyl)methyla mino]-.alpha.-[(3,4-difluorophenoxy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-[(2-benzothiazolyl)methyla mino]-.alpha.-[(3,4-difluorophenoxy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-[(2-benzothiazolyl)methyla mino]-.alpha.-[(3,4-difluorophenoxy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2189051